QuantRx Granted 510(k) Clearance for RapidSense Methamphetamine Test
QuantRx Biomedical Corporation has announced that the FDA has granted the Company 510(k) clearance on its RapidSense drugs-of-abuse (DOA) Methamphetamine test.
Read MoreMonth: January 2009
News Story #15563
AUTOMATION Infinite Microplate Readers Flexible, highly sensitive analysis Tecan, Männedorf, Switzerland, has been granted DLReady™ certification status for its high-end multimode readers Infinite® M1000 and Infinite F500 by Promega Corp
Read MoreVicor Receives 510(k) Approval to Market PD2i Analyzer
Vicor Technologies Inc, announces that it has received FDA 510(k) approval (K082709) to market its PD2i Analyzer, permitting immediate commercialization of the technology.
Read More
News Story #15562
G8 Automated Glycohemoglobin Analyzer Results in less than 2 minutes The Automated Glycohemoglobin Analyzer HLC-723G8 (G8) from Tosoh Bioscience, Tokyo, provides fast results with an HbA1c analysis time of only 1.6 minutes. Features inclu
Read MoreDxS extends EGFR license with Genzyme Genetics
DxS Ltd has expanded its license with Genzyme Genetics, a business unit of Genzyme Corporation, for epidermal growth factor receptor (EGFR) to include the United States and Canada.
Read More